Marketing compliance in UK telehealth is where most brand-level regulatory breaches happen. The rules are clear, the enforcement is real, and the failure modes are well-catalogued. This piece walks through how ASA, CAP, and the ad platforms interact, what Rule 12 of the CAP Code actually requires, and how to set up a pre-publication process that prevents the common breaches.
How the UK advertising regulator stack actually works
The UK advertising regulator stack has three layers. CAP writes the codes. ASA enforces the codes for non-broadcast advertising. Ad platforms (Meta, Google, TikTok) enforce their own policies on top, which are often stricter than CAP for prescription medicines. A campaign can be CAP-compliant and still rejected by Meta's policy team, or vice versa.
Specific CAP Code sections that apply to pharma/health adverts
CAP Code Rule 12 governs medicines, medical devices, health-related products, and beauty products. Rule 15 covers food and food supplements. Both restrict efficacy claims, comparative claims, and condition-led messaging. Rule 12.1 prohibits ads for medicinal products from appealing to children. Rule 12.5 restricts testimonial-based claims. Rule 12.6 restricts efficacy claims.
Pre-launch checks — Copy Advice from CAP, what they review and how long it takes
CAP Copy Advice is a free pre-publication service for advertisers. Submit your copy and CAP returns guidance on whether it is likely to comply. Turnaround is typically 5-10 working days. The service is responsive and operators who use it consistently have notably lower breach rates.
Conditional-language pitfalls — 'cure', 'guaranteed', 'lose X kg'
Specific language patterns that consistently trigger adjudications include: 'cure' (implies certainty of outcome), 'guaranteed results' (implies certainty without substantiation), 'lose X kg in Y weeks' (specific outcome claims require specific substantiation), and 'safe and effective' (implies absence of side effects). Operators learn to use specific evidence-supported language instead.
Influencer and affiliate compliance — disclosures, prescription discussions
Influencer disclosures must use #Ad or equivalent prominent labelling under ASA guidance. Prescription-only medicines cannot be discussed by name by paid influencers to the UK public. Affiliate links count as commercial relationships requiring disclosure. ASA has issued adjudications against multiple UK telehealth brands and their influencer partners over inadequate disclosures.
What happens when ASA flags an ad — the takedown and adjudication process
ASA can issue ad alerts directing UK advertisers to stop carrying specific marketing. ASA can publish adjudications naming non-compliant advertisers on its public site. Persistent CAP breaches can lead to ad-platform sanctions and removal from listings. The reputational cost of an adjudication usually exceeds the campaign-pull cost.
ASA can publish adjudications naming non-compliant advertisers on its public site. The reputational cost is usually worse than the campaign-pull cost.
The first time a regulator engages with you should not be in response to your launch campaign.
Marketing compliance is operational discipline. The brands that invest in pre-publication review, internal copy leads, and trained marketing teams spend less on regulatory remediation than the brands that don't. The discipline pays for itself within the first few campaigns.
